Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression

Trifluridine/tipiracil (FTD/TPI or TFTD, also known as TAS-102) is a combination of the antineoplastic thymidine analog, FTD, and thymidine phosphorylase inhibitor, TPI (molar ratio 1:0.5). FTD/TPI was approved in Japan, the United States, and the European Union for the treatment of unresectable adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Kazuaki, Nakagawa, Fumio, Kobunai, Takashi, Takechi, Teiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862589/
https://www.ncbi.nlm.nih.gov/pubmed/29568368
http://dx.doi.org/10.18632/oncotarget.24412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862589/
https://www.ncbi.nlm.nih.gov/pubmed/29568368
http://dx.doi.org/10.18632/oncotarget.24412

Ejemplares similares